274 related articles for article (PubMed ID: 28599348)
1. A pilot, open-label, 8-week study evaluating the efficacy, safety and tolerability of adjunctive minocycline for the treatment of bipolar I/II depression.
Soczynska JK; Kennedy SH; Alsuwaidan M; Mansur RB; Li M; McAndrews MP; Brietzke E; Woldeyohannes HO; Taylor VH; McIntyre RS
Bipolar Disord; 2017 May; 19(3):198-213. PubMed ID: 28599348
[TBL] [Abstract][Full Text] [Related]
2. Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial.
Husain MI; Chaudhry IB; Khoso AB; Husain MO; Hodsoll J; Ansari MA; Naqvi HA; Minhas FA; Carvalho AF; Meyer JH; Deakin B; Mulsant BH; Husain N; Young AH
Lancet Psychiatry; 2020 Jun; 7(6):515-527. PubMed ID: 32445690
[TBL] [Abstract][Full Text] [Related]
3. Adjunctive minocycline treatment for major depressive disorder: A proof of concept trial.
Dean OM; Kanchanatawan B; Ashton M; Mohebbi M; Ng CH; Maes M; Berk L; Sughondhabirom A; Tangwongchai S; Singh AB; McKenzie H; Smith DJ; Malhi GS; Dowling N; Berk M
Aust N Z J Psychiatry; 2017 Aug; 51(8):829-840. PubMed ID: 28578592
[TBL] [Abstract][Full Text] [Related]
4. Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial.
Savitz JB; Teague TK; Misaki M; Macaluso M; Wurfel BE; Meyer M; Drevets D; Yates W; Gleason O; Drevets WC; Preskorn SH
Transl Psychiatry; 2018 Jan; 8(1):27. PubMed ID: 29362444
[TBL] [Abstract][Full Text] [Related]
5. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
[TBL] [Abstract][Full Text] [Related]
6. A pilot study of brexpiprazole for bipolar depression.
Brown ES; Khaleghi N; Van Enkevort E; Ivleva E; Nakamura A; Holmes T; Mason BL; Escalante C
J Affect Disord; 2019 Apr; 249():315-318. PubMed ID: 30802696
[TBL] [Abstract][Full Text] [Related]
7. Minocycline as an adjunct for treatment-resistant depressive symptoms: A pilot randomised placebo-controlled trial.
Husain MI; Chaudhry IB; Husain N; Khoso AB; Rahman RR; Hamirani MM; Hodsoll J; Qurashi I; Deakin JF; Young AH
J Psychopharmacol; 2017 Sep; 31(9):1166-1175. PubMed ID: 28857658
[TBL] [Abstract][Full Text] [Related]
8. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
[TBL] [Abstract][Full Text] [Related]
9. A prospective, open-label study of Aripiprazole mono- and adjunctive treatment in acute bipolar depression.
Dunn RT; Stan VA; Chriki LS; Filkowski MM; Ghaemi SN
J Affect Disord; 2008 Sep; 110(1-2):70-4. PubMed ID: 18272230
[TBL] [Abstract][Full Text] [Related]
10. Effect of Minocycline on Depressive Symptoms in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.
Hellmann-Regen J; Clemens V; Grözinger M; Kornhuber J; Reif A; Prvulovic D; Goya-Maldonado R; Wiltfang J; Gruber O; Schüle C; Padberg F; Ising M; Uhr M; Friede T; Huber C; Manook A; Baghai TC; Rupprecht R; Heuser I
JAMA Netw Open; 2022 Sep; 5(9):e2230367. PubMed ID: 36103181
[TBL] [Abstract][Full Text] [Related]
11. Open-label adjunctive topiramate in the treatment of unstable bipolar disorder.
McIntyre RS; Riccardelli R; Binder C; Kusumakar V
Can J Psychiatry; 2005 Jun; 50(7):415-22. PubMed ID: 16086539
[TBL] [Abstract][Full Text] [Related]
12. Melancholic Symptoms in Bipolar II Depression and Responsiveness to Lamotrigine in an Exploratory Pilot Study.
Peters EM; Bowen R; Balbuena L
J Clin Psychopharmacol; 2018 Oct; 38(5):509-512. PubMed ID: 30124585
[TBL] [Abstract][Full Text] [Related]
13. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
[TBL] [Abstract][Full Text] [Related]
14. A pilot study of minocycline for the treatment of bipolar depression: Effects on cortical glutathione and oxidative stress in vivo.
Murrough JW; Huryk KM; Mao X; Iacoviello B; Collins K; Nierenberg AA; Kang G; Shungu DC; Iosifescu DV
J Affect Disord; 2018 Apr; 230():56-64. PubMed ID: 29407539
[TBL] [Abstract][Full Text] [Related]
15. A placebo-controlled, random-assignment, parallel-group pilot study of adjunctive topiramate for patients with schizoaffective disorder, bipolar type.
Roy Chengappa K; Kupfer DJ; Parepally H; John V; Basu R; Buttenfield J; Schlicht P; Houck P; Brar JS; Gershon S
Bipolar Disord; 2007 Sep; 9(6):609-17. PubMed ID: 17845276
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II Depression: A Randomized Clinical Trial.
McIntyre RS; Subramaniapillai M; Lee Y; Pan Z; Carmona NE; Shekotikhina M; Rosenblat JD; Brietzke E; Soczynska JK; Cosgrove VE; Miller S; Fischer EG; Kramer NE; Dunlap K; Suppes T; Mansur RB
JAMA Psychiatry; 2019 Aug; 76(8):783-790. PubMed ID: 31066887
[TBL] [Abstract][Full Text] [Related]
17. Lurasidone adjunctive with lithium or valproate for bipolar depression: A placebo-controlled trial utilizing prospective and retrospective enrolment cohorts.
Suppes T; Kroger H; Pikalov A; Loebel A
J Psychiatr Res; 2016 Jul; 78():86-93. PubMed ID: 27089521
[TBL] [Abstract][Full Text] [Related]
18. Improving outcomes in depression: a focus on somatic symptoms.
McIntyre RS; Konarski JZ; Mancini DA; Zurowski M; Giacobbe P; Soczynska JK; Kennedy SH
J Psychosom Res; 2006 Mar; 60(3):279-82. PubMed ID: 16516660
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical Trial.
Quiroz JA; Tamburri P; Deptula D; Banken L; Beyer U; Rabbia M; Parkar N; Fontoura P; Santarelli L
JAMA Psychiatry; 2016 Jul; 73(7):675-84. PubMed ID: 27304433
[TBL] [Abstract][Full Text] [Related]
20. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.
Amsterdam JD; Wang CH; Shwarz M; Shults J
J Affect Disord; 2009 Jan; 112(1-3):219-30. PubMed ID: 18486235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
